Skip to content

Magnesium and sleep latency: grade C

Limited evidence. Direction: Benefit.

Evidence maturity: EmergingShort-term only

Why this grade

Rubric condition met: C: results only in older or clinical populations (older adults with insomnia), extrapolated to healthy adults

A 2021 meta-analysis of 3 RCTs in 151 older adults with insomnia found sleep onset latency 17.36 minutes shorter with magnesium than placebo, but all trials were at moderate-to-high risk of bias and the evidence was low to very low quality. One contributing trial had 46 older adults. A 2026 systematic review that included insomnia trials found results inconsistent across self-reported, EEG and actigraphy measures and rated certainty low to very low. No pooled estimate exists for healthy adults.

How sure are we?

Evidence maturity: Emerging Two or more RCTs, mainly in older adults with insomnia.

Tested as: Magnesium (mostly bisglycinate and other salts)

Who paid for the studies
Mixed
Risk of bias
Some concerns
Trial registry check
Not checked yet
Outcome measured
A test score, rating scale or performance measure
Who was studied
Clinical populations only
Rules applied
Population cap (logged, no further change): Older adults with insomnia
  • Could rise: Would move to B with an independent preregistered RCT in healthy adults positive on sleep latency as primary.
  • Could fall: Would move to N with two adequately sized independent null RCTs.

Science is provisional. This grade reflects the evidence we found as of . Next review: .

Maturity sits beside each grade. The grade says what the evidence shows; maturity says how much of it there is and how well it is confirmed.

Established
many trials from several independent teams, including at least one registered in advance
Emerging
two or more trials, or one large registered trial, not yet independently confirmed
Early signal
one trial, small pilots, or results only on secondary outcomes
Mechanistic only
lab, animal or biomarker data, or uncontrolled reports; no controlled human results
Traditional use only
a traditional-use monograph and nothing else

How we grade evidence

Studies this grade rests on

EffectMixedNo effectSize shows participants (n)20102015202020252030Meta-analysisSystematic reviewRCTMah 2021, 2021: meta-analysis, n = 151, result not recordedAbbasi 2012, 2012: RCT, n = 46, result not recordedLopresti 2026, 2026: systematic review, n not recorded, result not recorded
each study this grade rests on, by publication year and design. Solid: effect versus the comparator; half-filled: mixed; hollow: no effect; dashed: result not recorded yet. Larger marks had more participants.
Show the numbers
StudyYearDesignParticipantsResult
Abbasi 20122012RCT46result not recorded
Mah 20212021meta-analysis151result not recorded
Lopresti 20262026systematic reviewnot recordedresult not recorded

The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial.

Abbasi B, Kimiagar M, Sadeghniiat K. The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial J Res Med Sci, 2012. PMID 23853635

Result not recorded
Design
Randomized, double-blind, placebo-controlled trial, 8 weeks
Sample
n = 46
Population
Older adults with primary insomnia, Iran (clinical population)
Funding
not stated

Magnesium Supplementation for Sleep in Adults: A Systematic Review of Randomized Controlled Trials.

Lopresti AL, Smith SJ, Drummond PD. Magnesium Supplementation for Sleep in Adults: A Systematic Review of Randomized Controlled Trials J Diet Suppl, 2026. PMID 42661485

Result not recorded
Design
Systematic review of randomized controlled trials (12 in the main sleep synthesis), narrative synthesis with GRADE
Population
Adults (healthy and clinical samples)
Funding
not stated

Oral magnesium supplementation for insomnia in older adults: a Systematic Review & Meta-Analysis.

Mah J, Pitre T. Oral magnesium supplementation for insomnia in older adults: a Systematic Review & Meta-Analysis BMC Complement Med Ther, 2021. PMID 33865376

Result not recorded
Design
Systematic review and meta-analysis of 3 randomized placebo-controlled trials
Sample
n = 151
Population
Older adults with insomnia (clinical population; mean ages 59-65)
Funding
No specific grant (full text funding statement)

Search and history

Search (): magnesium[ti] AND (sleep[tiab] OR insomnia[tiab]) AND randomized controlled trial[pt] AND humans[mh]

  • Graded C (awaiting approval)
  • C to C (awaiting approval) (maturity: emerging): Maturity, bias summary and re-check date added
  • C to C (approved) (maturity: emerging): Editor sign-off November 16, 2026: grade matches the editor-approved final page